drugset / Trial / NCT00366119

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

NCT00366119

Phase 4 Unknown 86 enrolled Pacific Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess which drug is more effective of Ramiprin®(ramipril) and Tritace®(ramipril) in the Treatment of Essential Hypertension

Timeline

Start
2006-06
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule